RIP1-Tag2 positive mice that are serglycin deficient (RT2posSGko) develop a larger tumor mass with a better perfused vasculature than wild-type RIP1-Tag2 positive (RT2posSGwt) mice. The gene discussed is SRGN; the disease is neoplasm.